Literature DB >> 25787906

The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer.

Fanghua Qi1, Lin Zhao, Aiyan Zhou, Bo Zhang, Anyuan Li, Zhixue Wang, Junqing Han.   

Abstract

Recent studies indicate that Traditional Chinese medicine (TCM) can play an important role in the whole course of cancer treatment such as recovery stages of post-operative, radiotherapy or chemotherapy stages instead of only terminal stage of cancer. In this review, we have summarized current evidence for using TCM as adjuvant cancer treatment in different stages of cancer lesions. Some TCMs (e.g., TJ-41, Liu-jun-zi-tang, PHY906, Coumarin, and Aescine) are capable of improving the post-operative symptoms such as fatigue, pain, appetite, diarrhea, nausea, vomiting, and lymphedema. Some TCMs (e.g., Ginseng, Huang-Qi, BanZhiLian, TJ-48, Huachansu injection, Shenqi fuzheng injection, and Kanglaite injection) in combination with chemo- or radio-therapy are capable of enhancing the efficacy of and diminishing the side effects and complications caused by chemo- and radiotherapy. Taken together, they have great advantages in terms of suppressing tumor progression, relieving surgery complications, increasing the sensitivity of chemo- and radio- therapeutics, improving an organism's immune system function, and lessening the damage caused by surgery, chemo- or radio-therapeutics. They have significant effects on relieving breast cancer-related lymphedema, reducing cancer-related fatigue and pain, improving radiation pneumonitis and gastrointestinal side effects, protecting liver function, and even ameliorating bone marrow suppression. This review of those medicines should contribute to an understanding of Chinese herbal medicines as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer, by providing useful information for development of more effective anti-cancer drugs and making more patients "survival with cancer" for a long time.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25787906     DOI: 10.5582/bst.2015.01019

Source DB:  PubMed          Journal:  Biosci Trends        ISSN: 1881-7815            Impact factor:   2.400


  122 in total

1.  Efficacy of traditional Chinese medicine in treating cancer.

Authors:  Jiao Nie; Changlin Zhao; L I Deng; Jia Chen; Bin Yu; Xianlin Wu; Peng Pang; Xiaoyin Chen
Journal:  Biomed Rep       Date:  2015-11-05

Review 2.  A general description for Chinese medicine in treating premature ovarian failure.

Authors:  Jing Lin; Xue-Lian Li; Hui Song; Qian Li; Ming-Yan Wang; Xue-Min Qiu; Da-Jin Li; Ling Wang
Journal:  Chin J Integr Med       Date:  2017-03-07       Impact factor: 1.978

3.  Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy.

Authors:  Xue-Jia Kang; Hui-Yuan Wang; Hui-Ge Peng; Bin-Fan Chen; Wen-Yuan Zhang; Ai-Hua Wu; Qin Xu; Yong-Zhuo Huang
Journal:  Acta Pharmacol Sin       Date:  2017-05-08       Impact factor: 6.150

Review 4.  The vital role of ATP citrate lyase in chronic diseases.

Authors:  Amrita Devi Khwairakpam; Kishore Banik; Sosmitha Girisa; Bano Shabnam; Mehdi Shakibaei; Lu Fan; Frank Arfuso; Javadi Monisha; Hong Wang; Xinliang Mao; Gautam Sethi; Ajaikumar B Kunnumakkara
Journal:  J Mol Med (Berl)       Date:  2019-12-19       Impact factor: 4.599

Review 5.  Chinese medicine as complementary therapy for female infertility.

Authors:  Ju-Feng Xia; Yoshinori Inagaki; Jian-Feng Zhang; Ling Wang; Pei-Pei Song
Journal:  Chin J Integr Med       Date:  2016-08-02       Impact factor: 1.978

6.  Kanglaite inhibits the expression of drug resistance genes through suppressing PVT1 in cisplatin-resistant gastric cancer cells.

Authors:  Xian-Wen Zhang; Liang Liu; Xi-Zhi Zhang; Ping Bo
Journal:  Exp Ther Med       Date:  2017-06-22       Impact factor: 2.447

7.  Application of Computer-Aided Tongue Inspection for Preliminary Screening of Esophageal Cancer.

Authors:  Jin-Long Duan; Bo Deng; Guo-Hui Song; Zhi-Feng Chen; Yan-Wei Gong; Yu-Hua He; Li-Qun Jia
Journal:  Chin J Integr Med       Date:  2018-04-17       Impact factor: 1.978

8.  Shenmai injection enhances the cytotoxicity of chemotherapeutic drugs against colorectal cancers via improving their subcellular distribution.

Authors:  Wen-Yue Liu; Jing-Wei Zhang; Xue-Quan Yao; Chao Jiang; Ji-Chao He; Pin Ni; Jia-Li Liu; Qian-Ying Chen; Qing-Ran Li; Xiao-Jie Zang; Lan Yao; Ya-Zhong Liu; Mu-Lan Wang; Pei-Qiang Shen; Guang-Ji Wang; Fang Zhou
Journal:  Acta Pharmacol Sin       Date:  2016-11-21       Impact factor: 6.150

9.  Primitive neuroectodermal tumor originating from the lung: A case report.

Authors:  Xin Jin; Jianfeng Cao; Yong Liu; Fang Bian; Qingqing Zhao; Yan Wang; Xu Lv; Yayong Huang
Journal:  Oncol Lett       Date:  2016-08-08       Impact factor: 2.967

Review 10.  Advances in Research on Anticancer Properties of Salidroside.

Authors:  An-Qi Sun; Xiu-Lian Ju
Journal:  Chin J Integr Med       Date:  2020-03-06       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.